Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    YFK   US88575Y1055

3SBIO INC. (ADR)

 (YFK)

0
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Quotes 5-day view   End-of-day quote. End-of-day quote Deutsche Boerse AG
05/13/2013 05/14/2013 05/15/2013 05/16/2013 05/17/2013 Date
12.421(c) 12.382(c) 12.497(c) 12.58(c) 12.568(c) Last
0 0 0 0 0 Volume
+0.39% -0.31% +0.93% +0.66% -0.10% Change
More quotes
Company
Sector
Biotechnology
Calendar
08/13Earnings Release
Surperformance© rating of 3SBio Inc. (ADR)
Trading Rating : Investor Rating :
More about the company
Chart 3SBIO INC. (ADR)
Duration : Period :
3SBio Inc. (ADR) Technical Analysis Chart | YFK | US88575Y1055 | 4-Traders
Full-screen chart
Financials ($)
Sales 2013 128 M
EBIT 2013 22,8 M
Net income 2013 18,7 M
Finance 2013 139 M
Yield 2013 -
Sales 2014 151 M
EBIT 2014 28,6 M
Net income 2014 -
Finance 2014 154 M
Yield 2014 -
PER 2013 20,48
PER 2014
EV / Sales 2013 1,96x
EV / Sales 2014 1,57x
Capitalization 391 M
More Financials
Latest news on 3SBIO INC. (ADR)
04/25 3SBIO INC. (ADR): 3SBio Inc. Adjourns Extraordinary General Meeting of Sharehol..
04/15 3SBIO INC. (ADR): OrbiMed Advisors Announces Institutional Shareholder Services..
04/12 3SBIO INC. (ADR): Glass Lewis Recommends 3SBio Shareholders Vote against Manage..
04/09DJU.S. HOT STOCK FUTURES: Hot stocks to watch
04/09DJU.S. HOT STOCK FUTURES: Hot stocks to watch
03/143SBIO INC. (ADR): quaterly earnings release
02/08DJU.S. HOT STOCK FUTURES: Hot stocks to watch
02/08DJ3SBIO INC. (ADR): 3SBio Agrees to Be Taken Private for $350 Million
20123SBIO INC. (ADR): quaterly earnings release
2012DJADR REPORT: Shares End Higher Ahead of Fed Statement
2012DJU.S. HOT STOCK FUTURES: Hot stocks to watch
2010 3SBIO INC ADR: Ascenta Therapeutics and Ascentage Pharma Sign R&D Collaboration..
More news
Forum 3SBIO INC. (ADR)
Advertisement
Income Statement Evolution
3SBio Inc. (ADR) : Income Statement Evolution
More Financials
EPS Revisions
3SBio Inc. (ADR) : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.